ArticleTranslational oncology2020

hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients.

Jessica Iorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.